Cynthia A. Challener

In a pandemic, genetic vaccines offer several advantages over traditional approaches.

Plasma-based proteins and cell-based therapies have significant potential to address unmet medical needs.

Connected, integrated bioprocessing enterprises with greater data analytics capabilities are coming.

Clear understanding of what exactly the biomolecule entails is essential.